Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections

Background: Little is known regarding the impact of the Food and Drug Administration (FDA) boxed warning on prescribing rates of fluoroquinolone (FQ) antibiotics in the outpatient setting. Objective: The primary objective of this study was to evaluate the 2016 FDA boxed warning update on FQ prescrib...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of pharmacotherapy 2019-12, Vol.53 (12), p.1192-1199
Hauptverfasser:	Cowart, Kevin, Worley, Marylee, Rouby, Nihal El, Sando, Karen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Drug Labeling - standards Drug Prescriptions - standards Drug Prescriptions - statistics & numerical data Female Fluoroquinolones - administration & dosage Fluoroquinolones - adverse effects Fluoroquinolones - therapeutic use Humans Logistic Models Male Middle Aged Outpatients Practice Patterns, Physicians' - standards Practice Patterns, Physicians' - statistics & numerical data Retrospective Studies United States United States Food and Drug Administration Urinary Tract Infections - drug therapy Urinary Tract Infections - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!